Iqvia Holdings Inc (NYSE:IQV) Insider Sells $999,700.00 in Stock

Iqvia Holdings Inc (NYSE:IQV) insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total transaction of $999,700.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Iqvia Holdings Inc (NYSE IQV) traded up $2.58 during midday trading on Monday, reaching $98.63. 1,258,340 shares of the company’s stock were exchanged, compared to its average volume of 1,138,950. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. The company has a market cap of $19,980.00, a P/E ratio of 340.10, a P/E/G ratio of 1.31 and a beta of 0.61. Iqvia Holdings Inc has a 52-week low of $75.94 and a 52-week high of $110.67.

Several analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of Iqvia from $96.00 to $121.00 and gave the stock an “overweight” rating in a report on Thursday, November 9th. Zacks Investment Research raised shares of Iqvia from a “hold” rating to a “buy” rating and set a $114.00 target price for the company in a report on Saturday, October 21st. Barclays lifted their target price on shares of Iqvia from $100.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, October 27th. Stifel Nicolaus raised shares of Iqvia from a “hold” rating to a “buy” rating and lifted their target price for the stock from $92.00 to $128.00 in a report on Friday, October 27th. Finally, Mizuho set a $97.00 target price on shares of Iqvia and gave the stock a “hold” rating in a report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $109.71.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Winslow Evans & Crocker Inc. bought a new stake in Iqvia in the 4th quarter valued at about $123,000. Valeo Financial Advisors LLC acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $170,000. IFP Advisors Inc acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $200,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $209,000. Finally, Atria Investments LLC acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $218,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Iqvia Holdings Inc (NYSE:IQV) Insider Sells $999,700.00 in Stock” was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.thelincolnianonline.com/2018/02/12/james-h-erlinger-iii-sells-10000-shares-of-iqvia-holdings-inc-iqv-stock-updated-updated-updated.html.

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Insider Buying and Selling by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply